Rosenwald Lindsay A MD's Form 4 filing
Fortress Biotech, Inc. (FBIO) · filed Aug 21, 2023
- Accession no.
- 0001104659-23-093700
- Filed
- Aug 21, 2023
- Trade date
- Aug 17-18, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $210.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenwald Lindsay A MDCIK 0000941841 | Director, Officer (President, CEO & Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | PPurchaseAcquired | +10,000 | $11.75 | +$117,500 | 102,500 | Direct | |
| Aug 18, 2023 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | PPurchaseAcquired | +10,000 | $9.34 | +$93,400 | 112,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.